Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
The AAPS Journal|May 28, 2020
Physiologically Based Absorption Modelling to Explore the Impact of Food and Gastric pH Changes on the Pharmacokinetics of EntrectinibNeil Parrott, Cordula Stillhart, Marc Lindenberg, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2015
Preclinical pharmacokinetics, pharmacodynamics, and efficacy of RG7116: a novel humanized, glycoengineered anti-HER3 antibodyGeorgina Meneses-Lorente, Thomas Friess, Irene Kolm, et al.
Journal of Clinical Pharmacology|May 22, 2010
Coadministration of dalcetrapib with pravastatin, rosuvastatin, or simvastatin: no clinically relevant drug-drug interactionsMichael Derks, Markus Abt, Mary Phelan, et al.
Cancer Chemotherapy and Pharmacology|June 20, 2018
A continuous-time multistate Markov model to describe the occurrence and severity of diarrhea events in metastatic breast cancer patients treated with lumretuzumab in combination with pertuzumab and paclitaxelChao Xu, Patanjali Ravva, Jun Steve Dang, et al.
Cancer Chemotherapy and Pharmacology|September 18, 2021
Population pharmacokinetic analysis of entrectinib in pediatric and adult patients with advanced/metastatic solid tumors: support of new drug application submissionMario González-Sales, Nassim Djebli, Georgina Meneses-Lorente, et al.
Archives of Toxicology|June 25, 2025
In silico & in vitro approaches suggest osteoclastogenesis induction underlying fractures in Entrectinib-treated childrenSabrina Ehnert, Andreas K Nüssler, Kevin A Schulz, et al.
European Journal of Drug Metabolism and Pharmacokinetics|September 8, 2021
Physiologically-Based Pharmacokinetic Modelling of Entrectinib Parent and Active Metabolite to Support Regulatory Decision-MakingNassim Djebli, Vincent Buchheit, Neil Parrott, et al.
Clinical Pharmacology and Therapeutics|June 24, 2020
PK/PD Mediated Dose Optimization of Emactuzumab, a CSF1R Inhibitor, in Patients With Advanced Solid Tumors and Diffuse-Type Tenosynovial Giant Cell TumorKevin Smart, Ann-Marie Bröske, Dominik Rüttinger, et al.
Proteomics|July 23, 2003
Multiplex proteomic analysis by two-dimensional differential in-gel electrophoresisMichael R Knowles, Sandra Cervino, Heather A Skynner, et al.
Investigational New Drugs|January 19, 2021
Characterization of the pharmacokinetics of entrectinib and its active M5 metabolite in healthy volunteers and patients with solid tumorsGeorgina Meneses-Lorente, Darren Bentley, Elena Guerini, et al.
Pageof 4